Advancements in Nano Drug Delivery for Targeted Treatment of Brain Tumors: Breaking Barriers for Enhanced Therapeutic Outcomes

Abstract

Brain tumors provide a health obstacle characterized by an intricate past closely linked to medical progress. The need to tackle this matter stems from the significant influence of brain tumors on cognitive performance and general welfare. The current treatment options face difficulties, mainly because of the complex blood-brain barrier and the need for accurate medication administration at the tumor location. This research promotes the use of Nano Drug Delivery for Targeted Treatment of Brain Tumors (NDD-T2BT), acknowledging the crucial importance of nanotechnology in addressing these difficulties. NDD-T2BT utilizes sophisticated nanocarriers to augment medication concentration, specifically at the tumor site, provoke immunological responses, and promote the permeability of the blood-brain barrier. The proposed method, characterized by the mean values of necessary measurements (62.87% drug concentration, 1888.78 cells/μL immune response activation, 0.0910 cm/s barrier permeability, and 91.23% tumor cell viability reduction), effectively overcomes the shortcomings of current therapies. The results highlight the potential of NDD-T2BT to transform the treatment of brain tumors by providing a complete and precise strategy that shows promise for improved therapeutic outcomes.